US2005238687A1PendingUtilityA1
Methods and compositions of bioartificial kidney suitable for use in vivo or ex vivo
Est. expirySep 30, 2016(expired)· nominal 20-yr term from priority
Inventors:H. David Humes
B01D 67/0088C12N 2502/1347C12N 5/0686C12N 2510/00C12N 2510/02C12M 25/10C12N 5/0697C12N 2502/28C12M 21/08B01D 69/00C12N 2502/256A61M 1/16A61M 1/1678A61M 1/3489A61M 1/3689A61M 1/28A61M 1/3687B01D 69/141A61K 35/14
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel cell seeded hollow fiber bioreactor is described as a potential bioartificial kidney. Endothelial cells along with pericyte, vascular smooth muscle, and/or mesangial cells or any mesenchymally derived support cells are seeded along a hollow fiber in a perfused bioreactor to reproduce the ultrafiltration function and transport function of the kidney. Maintenance of tissue specific function and ultrastructure suggest that this bioreactor provides an economical device for treating renal failure.
Claims
exact text as granted — not AI-modified1 . A bioartificial device, comprising a semipermeable surface coated with (i) a layer of nonimmortalized endothelial cells, epithelial cells, or a mixture thereof and (ii) pericyte, vascular smooth muscle or mesangial cells or a mixture thereof,
wherein one side of said semipermeable surface is in fluid communication with a blood inlet and the other side is in fluid communication with a blood outlet.
2 . The bioartificial device according to claim 1 , which is a reabsorption device and wherein said layer (i) comprises renal tubule cells.
3 . The bioartificial device of claim 1 , which is a filtration device and wherein said layer (i) comprises renal endothelial cells and pericyte, vascular smooth muscle or mesangial cells or a mixture thereof.
4 . The bioartificial filtration device according to claim 1 , wherein said pericyte cells (ii) are mesangial cells.
5 . The bioartificial filtration device according to claim 1 , comprising at least a 1:1 ratio of (a) endothelial cells to (b) pericyte, vascular smooth muscle or mesangial cells or a mixture thereof.Join the waitlist — get patent alerts
Track US2005238687A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.